Patents Assigned to Jenrin Discovery, LLC - Justia Patents Search

Patents Assigned to Jenrin Discovery, LLC

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

Patent number: 11179370

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: March 4, 2020

Date of Patent: November 23, 2021

Assignee: Jenrin Discovery, LLC

Inventors: John F McElroy, Robert J. Chorvat
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Patent number: 10617673

Abstract: The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.

Type: Grant

Filed: May 29, 2018

Date of Patent: April 14, 2020

Assignee: Jenrin Discovery, LLC

Inventors: John F McElroy, Robert J Chorvat